Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stratton

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
The design of 8,8-dimethyl[1,6]naphthyridines as potential anticonvulsant agentsNigel E Austin, Michael S Hadley, John D Harling, et al.
Physical Review Letters|September 5, 2001
Observation of zero current density in the core of jet discharges with lower hybrid heating and current driveN C Hawkes, B C Stratton, T Tala, et al.
ESMO Open|April 10, 2022
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancerM Stares, T E Ding, C Stratton, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2008
Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurinesRoger J Gillespie, Ian A Cliffe, Claire E Dawson, et al.
Bioorganic & Medicinal Chemistry|August 22, 2009
Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamidesRoger J Gillespie, Samantha J Bamford, Alex Clay, et al.
The Journal of Physical Chemistry. A|June 24, 2022
Synthesis and Optical Characterization of a Rhodamine B Spirolactam DimerBrandy-Fey C Stratton, Angelina J Pierre, Elizabeth A Riser, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitizationSharon Bingham, Paul J Beswick, Chas Bountra, et al.
Journal of Medicinal Chemistry|December 17, 2008
Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidinesRoger J Gillespie, Samantha J Bamford, Ruth Botting, et al.
Molecular Cancer Therapeutics|July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivoSarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2013
Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancerRobert H Bradbury, David G Acton, Nicola L Broadbent, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
The design of 8,8-dimethyl[1,6]naphthyridines as potential anticonvulsant agentsNigel E Austin, Michael S Hadley, John D Harling, et al.
Physical Review Letters|September 5, 2001
Observation of zero current density in the core of jet discharges with lower hybrid heating and current driveN C Hawkes, B C Stratton, T Tala, et al.
ESMO Open|April 10, 2022
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancerM Stares, T E Ding, C Stratton, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2008
Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurinesRoger J Gillespie, Ian A Cliffe, Claire E Dawson, et al.
Bioorganic & Medicinal Chemistry|August 22, 2009
Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamidesRoger J Gillespie, Samantha J Bamford, Alex Clay, et al.
The Journal of Physical Chemistry. A|June 24, 2022
Synthesis and Optical Characterization of a Rhodamine B Spirolactam DimerBrandy-Fey C Stratton, Angelina J Pierre, Elizabeth A Riser, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitizationSharon Bingham, Paul J Beswick, Chas Bountra, et al.
Journal of Medicinal Chemistry|December 17, 2008
Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidinesRoger J Gillespie, Samantha J Bamford, Ruth Botting, et al.
Molecular Cancer Therapeutics|July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivoSarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2013
Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancerRobert H Bradbury, David G Acton, Nicola L Broadbent, et al.
Pageof 8